Site Under Development, Content Population and SEO, Soft Launch 1st January 2020

  Nov 17, 2018
Alere DDS®2 Mobile Test System for Rapid Screening for Drugs of Abuse in Oral Fluid
Alere DDS®2 Mobile Test System for Rapid Screening for Drugs of Abuse in Oral Fluid
  Nov 17, 2018


The Alere DDS®2 Mobile Test System is a portable system designed for rapid screening and detection for drugs of abuse in oral fluid. With test results in 5 minutes, the battery-operated device is portable, lightweight, and easy to use, making it ideal for roadside drug screening.

Benefits

Robust Design

The Alere DDS2 was developed to meet the high performance demands of law enforcement agencies, drug treatment centers, and workplace environments.

Reliable Results

Alere DDS2 combines rapid drug screening and accurate result interpretation. With system analysis printouts on location, the DDS2 eliminates subjectivity and misinterpretation of test results for greater reliability.

Easy to Use

With an intuitive test process, the Alere DDS2 Mobile Test System is incredibly easy to use in any environment. The system is lightweight, portable and compact with a full color screen, readable day and night.

Simple Collection Process

Rapid oral fluid collections are easy to obtain while in the field and less invasive than urine or blood sampling. The observed collection process limits adulteration and tampering concerns.

Manage Results

The analyzer can store 10,000 results which can be printed at the end of the test or reprinted from memory card. Test data can be downloaded to the optional Alere™ Software Application Suite for enhanced data management capabilities.

Specifications

The Alere DDS®2 Mobile Test System is available with a five or six panel test cartridge.

Drug Class

Cutoff (ng/mL)

Amphetamine

50

Benzodiazepines

20

Cannabis (THC)

25

Cocaine

30

Methamphetamine

50

Opiates

40

Methadone

15


For more detail: https://www.news-medical.net/ads/abmc.aspx?b=1964
Request a Quote
for Alere DDS®2 Mobile Test System for Rapid Screening for Drugs of Abuse in Oral Fluid